Hovione to expand its New Jersey facility
Will add around 60 new jobs to the current workforce at the plant
Portuguese active pharmaceutical ingredients (APIs) and intermediates manufacturer Hovione is expanding its New Jersey facility in East Windsor, US to meet the increasing demands of its customers and to give them more options for spray drying manufacturing.
The expansion will add 30,600ft2 (2,843m2) to the 24,000ft2 (2,211m2) facility. It will include a new commercial spray dryer unit to complement the firm's existing pilot unit and this installation will be specifically designed to handle potent drug substances (APIs).
Drug substance capacity will also more than double at the site to support the needs of current and potential new customers.
Hovione said around 60 new jobs will be added to the current workforce at the plant.
'Expanding our manufacturing presence in the US highlights our commitment to our customers that want to manufacture their products in the US and to support the development needs of our ever expanding local customer base.
'The additional capacity will give us more flexibility and make us more agile to deal with our customer’s fast-paced projects,' said Dr Marco Gil, General Manager, Hovione New Jersey.
Dave Hoffman, President of Hovione's US Operations, said: 'This investment pays a tribute to the excellent work that the Hovione New Jersey team has done to create a sustainable business for the company in the US. We trust the team in New Jersey to be an integral part of Hovione’s overall expansion.'
The official ground breaking should occur in the first quarter of 2016 and the doubling of capacity is expected to be fully operational in early 2017.
